Could your weight change your medication dose?
NCT ID NCT05584631
Summary
This study aims to understand how a person's body composition (like muscle and fat) affects the levels of immunoglobulin medication in their blood. It will enroll 20 adults with a nerve disorder called CIDP who receive this medication. Researchers will measure drug levels after patients receive it through an IV and under the skin to see if current weight-based dosing is accurate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers, The State University of New Jersey Clinical Research Center
RECRUITINGNew Brunswick, New Jersey, 08901, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.